X

Medicare Monday: What they are saying about MedPAC’s recommendations

Allyson Funk   |     June 20, 2016   |   SHARE THIS

MedMon_Catalyst_Banner.jpgBack in April, we previewed MedPAC’s recommendations and expressed concern and opposition to the sweeping recommended changes to Part D that taken together could harm beneficiaries by eroding coverage and protections for many of the most vulnerable enrollees in the program.

In the wake of MedPAC’s June 2016 report, a broad group of stakeholders has weighed in with concern about these recommendations and their negative impact on beneficiaries. Here’s a look at what they are saying.

  • Avalere Health noted in Kaiser Health News, “For many people, this [the proposal] will actually increase spending, while our results aren’t finalized yet, our generalized finding is that a small number of beneficiaries would save a lot of money … but a lot would spend more.”
  • The Partnership for Part D Access said to POLITICO, it “will continue to fight for the most vulnerable Medicare beneficiaries to have access to the full range of therapeutic options.”
  • America’s Health Insurance Plans raised concern in POLITICO that some proposals could “jeopardize the program’s affordability for beneficiaries.”
  • The National Alliance for Mental Health told The New York Times in April, the proposals “could adversely affect people with serious mental illness who are below the poverty level.”
  • Morning Consult reported in April that more than 250 groups asked MedPAC not to move forward with the proposals. The groups said, “Generic utilization is already high among Part D beneficiaries and has increased every year since the program began […] Further, increased cost sharing for vulnerable beneficiaries could reduce adherence, increase spending on other health care services, and worsen health outcomes.”

tn_MedMon.jpgFor more on Medicare Part D, visit phrma.org/PartD.

Allyson Funk

Allyson Funk Ally is a former senior director of public affairs at PhRMA focused on advocacy issues for the biopharmaceutical industry. Her expertise includes Medicare, Medicaid, 340B, health reform and more. Prior to PhRMA, her experience included leading health communications for a large membership organization, supporting public affairs clients and working for the governor of Louisiana.

Topics: Part D, Medicare, Medicare Monday

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates